Melagatran. Exanta, H 319/68.
D000818:Animals; D001384:Azetidines; D001596:Benzylamines; D004285:Dogs; D005343:Fibrinolytic Agents / Q000009:adverse effects / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D005998:Glycine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000493:pharmacokinetics / Q000494:pharmacology / Q000627:therapeutic use*; D006801:Humans; D051379:Mice; D013927:Thrombosis / Q000188:drug therapy*
D001384:Azetidines; D001596:Benzylamines; D005343:Fibrinolytic Agents; C109573:melagatran; D005998:Glycine